CAR T versus autologous Transplant (CAR T in a 2nd line setting) in lymphoma

On Monday, October 17, at 12 PM CDT, ASTCT hosted its fourth webinar in the 2022 ASTCT CAR T Webinar Series. Drs. Jeremy Abramson and Mazyar Shadman will review the three phase 3 trials (ZUMA-7, TRANSFORM, BELINDA) and discuss how the clinical trial data can be applied to actual non-study patients. After the review of the trials and the data, Drs. Abramson and Shadman will engage in a panel discussion.

Moderator: 

Dr. Antonio Vaz de Macedo; Head of the Hematology Clinic, Hospital da Polícia Militar, Brazil

Speakers:

Dr. Jeremy Abramson; Director, Jon and Jo Ann Hagler Center for Lymphoma, Massachusetts General Hospital Cancer Center. Associate Professor of Medicine, Harvard Medical School

Dr. Mazyar Shadman; Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center

Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.